ArticleFrontiers in pharmacology2022
Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China.
Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis.Human vaccines & immunotherapeutics · 2025Pooled it
- Household and Community Clustering of Concurrent Vaccine Hesitancy in China: Multicenter Survey.JMIR public health and surveillance · 2026Article
- Paying in public: Peer effects, impression management, and willingness to pay on digital payment platforms.PloS one · 2026Article
- Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China.Human vaccines & immunotherapeutics · 2024Article
- The present value of human life losses associated with COVID-19 and likely productivity losses averted through COVID-19 vaccination in Madagascar.BMC public health · 2024Article
- Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country.PharmacoEconomics - open · 2024Article
- Factors influencing Thai university students' decisions to take COVID-19 vaccine booster doses: a cross-sectional survey.Tropical medicine and health · 2024Article
- Sex differences in the relationship between post-vaccination adverse reactions, decision regret, and WTP for the booster dose of COVID-19 vaccine in Taizhou, China.Preventive medicine reports · 2024Article
- Preferences regarding COVID-19 vaccination among 12,000 adults in China: A cross-sectional discrete choice experiment.PLOS global public health · 2024Article
- Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study.Human vaccines & immunotherapeutics · 2023Article
- Can Patients with Asymptomatic/Mild Illness and Moderate Illness COVID-19 Have White Matter Damage?International journal of general medicine · 2023Article
- Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia.Infectious disease reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.